1st Quarter - Report

PFIZER INC. for PFIZER INC.

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$2,740,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report (this page) Apr 20, 2022 $2,740,000 Replaced
1st Quarter - Amendment Sep 2, 2022 $3,820,000 Replaced
1st Quarter - Amendment May 16, 2023 $2,730,000 Yes

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

TRIPS Waiver General IP Issues Bayh-Dole March-In Rights

Contacted: State, Dept of (DOS); White House Office; Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); SENATE

Medicare/Medicaid MMM

Medicare Part D Coverage Gap Rebate Reform Out-of-Pocket Costs Government Negotiation in Medicare

LobbyistCovered position, as disclosed
PAULA BURG —
FRANCISCO CARRILLO —
EMILY MUELLER —
ANGELA WALKER RIEMER —
MATTHEW STROIA —
JENNIFER SWENSON WALTON —

Contacted: SENATE; Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Office of the Vice President of the United States; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); White House Office

Health Issues HCR

Drug Pricing Biosimilars Out-of-Pocket Costs Rebate Reform Vaccine Infrastructure/HR 3656 Excise Tax Antimicrobial Resistance/HR 3932 COVID Relief Package/Appropriations PDUFA

LobbyistCovered position, as disclosed
PAULA BURG —
FRANCISCO CARRILLO —
EMILY MUELLER —
ANGELA WALKER RIEMER —
MATTHEW STROIA —
JENNIFER SWENSON WALTON —

Contacted: Office of Management & Budget (OMB); Executive Office of the President (EOP); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); White House Office; Food & Drug Administration (FDA)

Bills named: H.R. 3656 (117th), H.R. 3932 (117th)

Taxation/Internal Revenue Code TAX

Comprehensive Corporate Tax Reform International Tax Reform OECD Profit Allocation U.S. Manufacturing Credits Build Back Better Act

LobbyistCovered position, as disclosed
CAROLINE MOODY SCHELLHAS —
MATTHEW STROIA —
JENNIFER SWENSON WALTON —

Contacted: HOUSE OF REPRESENTATIVES; Treasury, Dept of; Natl Economic Council (NEC); SENATE

Trade (domestic/foreign) TRD

NAFTA/USMCA Foreign Market Access issues (including IPR) International Supply Chain/Buy America

LobbyistCovered position, as disclosed
ELISSA ALBEN —
CATHERINE ROBINSON —

Contacted: State, Dept of (DOS); White House Office; U.S. Trade Representative (USTR); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.